LYFE Capital
About LYFE Capital
LYFE Capital is a life science investment firm.
Investment focus
Stages
Sectors
Portfolio (2 in our database)
Ansun BioPharmaAnsun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.Series B · $213M raisedKyverna TherapeuticsKyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.Series B · $110M raised